DK9091D0 - Fremgangsmaade til fremstilling af antistoffer - Google Patents

Fremgangsmaade til fremstilling af antistoffer

Info

Publication number
DK9091D0
DK9091D0 DK009091A DK9091A DK9091D0 DK 9091 D0 DK9091 D0 DK 9091D0 DK 009091 A DK009091 A DK 009091A DK 9091 A DK9091 A DK 9091A DK 9091 D0 DK9091 D0 DK 9091D0
Authority
DK
Denmark
Prior art keywords
autoantibodies
lymphocytes
recovering
autoimmune disease
producing
Prior art date
Application number
DK009091A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK009091A priority Critical patent/DK9091D0/da
Publication of DK9091D0 publication Critical patent/DK9091D0/da
Priority to AT92903564T priority patent/ATE140727T1/de
Priority to AU11855/92A priority patent/AU655001B2/en
Priority to PCT/DK1992/000012 priority patent/WO1992013065A1/en
Priority to ES92903564T priority patent/ES2091459T3/es
Priority to DK92903564.0T priority patent/DK0567532T3/da
Priority to EP92903564A priority patent/EP0567532B1/en
Priority to JP4503469A priority patent/JPH06504675A/ja
Priority to KR1019930702157A priority patent/KR930703433A/ko
Priority to DE69212461T priority patent/DE69212461T2/de
Priority to IL10069092A priority patent/IL100690A/en
Priority to GR960402664T priority patent/GR3021293T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Forging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
DK009091A 1991-01-18 1991-01-18 Fremgangsmaade til fremstilling af antistoffer DK9091D0 (da)

Priority Applications (12)

Application Number Priority Date Filing Date Title
DK009091A DK9091D0 (da) 1991-01-18 1991-01-18 Fremgangsmaade til fremstilling af antistoffer
DE69212461T DE69212461T2 (de) 1991-01-18 1992-01-16 Methode zur produktion von autoantikörpern
ES92903564T ES2091459T3 (es) 1991-01-18 1992-01-16 Un metodo de producir autoanticuerpos.
AU11855/92A AU655001B2 (en) 1991-01-18 1992-01-16 A method of producing autoantibodies
PCT/DK1992/000012 WO1992013065A1 (en) 1991-01-18 1992-01-16 A method of producing autoantibodies
AT92903564T ATE140727T1 (de) 1991-01-18 1992-01-16 Methode zur produktion von autoantikörpern
DK92903564.0T DK0567532T3 (da) 1991-01-18 1992-01-16 Fremgangsmåde til fremstilling af autoantistoffer
EP92903564A EP0567532B1 (en) 1991-01-18 1992-01-16 A method of producing autoantibodies
JP4503469A JPH06504675A (ja) 1991-01-18 1992-01-16 自己抗体の製造方法
KR1019930702157A KR930703433A (ko) 1991-01-18 1992-01-16 자기항체의 제조방법
IL10069092A IL100690A (en) 1991-01-18 1992-01-17 A method for the production of auto-antibodies that react with antigens of auto-immune disease
GR960402664T GR3021293T3 (en) 1991-01-18 1996-10-09 A method of producing autoantibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK009091A DK9091D0 (da) 1991-01-18 1991-01-18 Fremgangsmaade til fremstilling af antistoffer

Publications (1)

Publication Number Publication Date
DK9091D0 true DK9091D0 (da) 1991-01-18

Family

ID=8089624

Family Applications (2)

Application Number Title Priority Date Filing Date
DK009091A DK9091D0 (da) 1991-01-18 1991-01-18 Fremgangsmaade til fremstilling af antistoffer
DK92903564.0T DK0567532T3 (da) 1991-01-18 1992-01-16 Fremgangsmåde til fremstilling af autoantistoffer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92903564.0T DK0567532T3 (da) 1991-01-18 1992-01-16 Fremgangsmåde til fremstilling af autoantistoffer

Country Status (11)

Country Link
EP (1) EP0567532B1 (da)
JP (1) JPH06504675A (da)
KR (1) KR930703433A (da)
AT (1) ATE140727T1 (da)
AU (1) AU655001B2 (da)
DE (1) DE69212461T2 (da)
DK (2) DK9091D0 (da)
ES (1) ES2091459T3 (da)
GR (1) GR3021293T3 (da)
IL (1) IL100690A (da)
WO (1) WO1992013065A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
WO2002026829A1 (en) * 2000-09-25 2002-04-04 Rega Stichting Vzw Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis
GB2395270B (en) 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
SI1889059T1 (sl) 2005-05-27 2009-12-31 Oncimmune Ltd Izboljšani imunotestni postopek
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
WO2013098420A1 (en) 2011-12-28 2013-07-04 Immunoqure Ag Method of isolating human antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853201T2 (de) * 1987-12-23 1995-09-14 Univ Leland Stanford Junior Schimäre immunkompromittierende Säugetiere und ihre Verwendung.
JP2981486B2 (ja) * 1988-06-14 1999-11-22 メディカル・バイオロジー・インスティチュート 哺乳動物の免疫系研究方法
WO1991016910A1 (en) * 1990-05-03 1991-11-14 Systemix, Inc. Human lymphoid tissue in an immunocompromised host

Also Published As

Publication number Publication date
EP0567532B1 (en) 1996-07-24
IL100690A0 (en) 1992-09-06
KR930703433A (ko) 1993-11-30
GR3021293T3 (en) 1997-01-31
DK0567532T3 (da) 1996-11-11
EP0567532A1 (en) 1993-11-03
WO1992013065A1 (en) 1992-08-06
DE69212461T2 (de) 1996-12-12
AU655001B2 (en) 1994-12-01
ES2091459T3 (es) 1996-11-01
DE69212461D1 (de) 1996-08-29
IL100690A (en) 1996-09-12
JPH06504675A (ja) 1994-06-02
AU1185592A (en) 1992-08-27
ATE140727T1 (de) 1996-08-15

Similar Documents

Publication Publication Date Title
Bennett Biology and genetics of hybrid resistance
Golstein et al. Cells mediating specific in vitro cytotoxicity: ii. probable autonomy of thymus-processed lymphocytes (t cells) for the killing of allogeneic target cells
ATE203163T1 (de) Zellen mit mehreren geänderten epitopen auf einem oberflächeantigen zur verwendung in transplantation
DE69533912D1 (de) Antikörper gegen Epitope mit Homologie zu Auto-Antigenen, Verfahren zur Herstellung und deren Verwendungen
DK0432249T3 (da) Monoklonale antistoffer over for beta-kæden i leukocytadhæsionsreceptoren, fremgangsmåder til fremstilling af disse antistoffer og anvendelse heraf
SE8404962D0 (sv) Sett att inducera ett immunsvar i en djurkropp
KR880006357A (ko) 인터류킨-i에 대한 항체
Snow et al. Activation of antigen-enriched B cells. II. Role of linked recognition in B cell proliferation to thymus-dependent antigens.
Snow et al. Activation of antigen-enriched b cells. I. Purification and response to thymus-independent antigens.
DK9091D0 (da) Fremgangsmaade til fremstilling af antistoffer
NZ329314A (en) Hybridoma & method of preparing a monoclonal antibody reactive with hc gp-39, use & treatment of rheumatoid arthritis
Groves et al. Veterinary sources of nonrodent monoclonal antibodies: interspecific and intraspecific hybridomas
EP1161955A3 (en) Induction of immunological tolerance for graft transplantation by the use of humanized non-depleting anti-cd4 antibodies in combination with specific donor bone marrow cells
Iverson et al. The role of a carrier‐determinant and T cells in the induction of liver‐specific autoantibodies in the mouse
Phipps et al. A novel role for macrophages: the ability of macrophages to tolerize B cells.
Howard et al. The mechanism of graft rejection and the concept of antigenic strength
Hibi et al. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells.
EP0131415A3 (en) Monoclonal antibodies, processes for their preparation and methods for their use
Zöller et al. Specific cytotoxicity in vitro by T-cell-enriched lymphocyte subpopulations from rats bearing chemically induced but not spontaneous tumors
Prakapas et al. Analysis of early reconstitution events in the SCID mouse thymus following rat bone marrow cell transplantation
JPS643199A (en) Monoclonal antibody
Bonavida et al. Function of Effector T Cells
James et al. Production of murine/guinea pig and rat/guinea pig heterohybridomas
Melchers et al. Activation and cell cycle control of murine B lymphocytes
Lai et al. Helper T cell lines to major and to minor histocompatibility antigens are equally effective in the regulation of B cell responses in vivo